Proceedings of the 9th Annual General Meeting of the Company held on September 25, 2026

Date: September 25, 2026 To, To, Sr. General Manager Sr. General Manager Listing Department Listing Department BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza, C-1, Block G Dalal Street Bandra Kurla Complex Mumbai – 400 001 Bandra (E), Mumbai – 400 051 BSE Scrip Code: 544319 NSE Symbol: SENORES Sub.: Proceedings of the Ninth (09th) Annual General Meeting of the Company held on September 25, 2026 Dear Sir/Madam, Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("SEBI LODR Regulations") we wish to inform that the 09th Annual General Meeting (“AGM”) of the Company was held today i.e. Friday, September 25, 2026, which commenced at 11:31 A.M. (IST) and concluded at 12:02 P.M. (IST) through Video Conferencing (“VC”) / Other Audio Visual Means (“OAVM”) facility. Pursuant to the provisions of Regulation 30 of the SEBI LODR Regulations, the proceedings of the AGM, is enclosed herewith as Annexure A. The same shall be made available on the website of the Company at www.senorespharma.com. Details of voting results as required under Regulation 44 (3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 will be submitted separately. All the Stakeholders are requested to take note of the same. Thanking you. For Senores Pharmaceuticals Limited Shilpa Sharma Company Secretary and Compliance Officer ICSI Membership No.: A34516 Encl.: As mentioned above Senores Pharmaceuticals Limited 1101 to 1103, 11th Floor, South Tower, One42, Opp. Jayantilal Park, Ambali Bopal Road, Ahmedabad-380054, Gujarat, India P: +91 79 2999 9857 | E: info@senorespharma.com W: www.senorespharma.com | CIN No.: L24290GJ2017PLC100263 Annexure A Proceedings of the Ninth (09th) Annual General Meeting ("AGM") of Senores Pharmaceuticals Limited held on Friday, September 25, 2026 at 11:31 A.M. (IST) and concluded at 12:02 P.M. (IST) through Video Conferencing ("VC") / Other Audio Visual Means ("OAVM") The Ninth (09th) Annual General Meeting (“AGM”) of Senores Pharmaceuticals Limited (“the Company”) held today on Friday, September 25, 2026 at 11:31 A.M. (IST), through Video Conferencing ("VC")/ Other Audio Visual Means (“OAVM”), in compliance with various General Circulars issued by the Ministry of Corporate Affairs (“MCA”) and the Securities and Exchange Board of India (“SEBI”) and as per applicable provisions of the Companies Act, 2013 and the Rules made thereunder. The Proceedings of the AGM of the Company was deemed to be held at Registered Of(cid:976)ice of the Company situated at 1101 to 1103, 11th Floor, South Tower, One42, Opp. Jayantilal Park, Ambali Bopal Road, Ahmedabad-380054, Gujarat, India. Following Directors and Key Managerial Personnel of the Company attended the AGM: Sr. Name of Person Designation 1. Mr. Sanjay Shaileshbhai Majmudar : Chairman and Non-Executive, Non- Independent Director 2. Mr. Swapnil Jatinbhai Shah : Managing Director 3. Mr. Deval Rajnikant Shah : Whole Time Director and Chief Financial Of(cid:976)icer 4. Mr. Arpit Deepakkumar Shah : Non-Executive, Non- Independent Director 5. Mr. Jitendra Babulal Sanghvi : Non-Executive, Non- Independent Director 6. Mr. Kalpit Rajesh Gandhi : Non-Executive, Independent Director 7. Mr. Udayan Dileep Choksi : Non-Executive, Independent Director 8. Mr. Naresh Bansilal Shah : Non-Executive, Non- Independent Director 9. Mr. Ashokkumar Vijaysinh Barot : Non-Executive, Non- Independent Director 10. Ms. Shilpa Sharma : Company Secretary and Compliance Of(cid:976)icer Authorised Representative of M/s Pankaj R. Shah & Associates, Chartered Accountants, Statutory Auditors, Authorised Representative of M/s Sharp and Tannan Associates, Chartered Accountants, Internal Auditors and Mr. Mukesh H. Shah, Proprietor of M/s Mukesh H. Shah & Co., Secretarial Auditor and Scrutinizer of the Company attended the meeting through Video Conferencing. 49 (Forty Nine) members attended the meeting through Video Conferencing including corporate bodies through their representative. Senores Pharmaceuticals Limited 1101 to 1103, 11th Floor, South Tower, One42, Opp. Jayantilal Park, Ambali Bopal Road, Ahmedabad-380054, Gujarat, India P: +91 79 2999 9857 | E: info@senorespharma.com W: www.senorespharma.com | CIN No.: L24290GJ2017PLC100263 Mr. Sanjay Shaileshbhai Majmudar, Chairman and Non-Executive, Non- Independent Director, chaired the Meeting and welcomed the members. After ascertaining that the requisite quorum being present, the Chairman called the meeting to order and proceeded further with the formal address. Thereafter, he requested Ms. Shilpa Sharma to take proceedings forward. The Company Secretary acknowledged the presence of other Board Members who attended the AGM. She also acknowledged the presence of M/s Pankaj R. Shah & Associates, Chartered Accountants, Statutory Auditor, M/s Sharp and Tannan Associates, Chartered Accountants, Internal Auditor and M/s Mukesh H. Shah & Co., Secretarial Auditor and Scrutinizer of the Company. Thereafter, she gave general instructions to the members regarding participation in the meeting. The members were inter-alia informed that in accordance with the provisions of the Companies Act, 2013, SEBI LODR Regulations and Secretarial Standards on General Meetings, the Company had provided the facility for casting the votes by the members through the e-voting system provided by MUFG Intime India Private Limited. The remote e-voting commenced on Tuesday, September 22, 2026 from 09:00 A.M. (IST) onwards and ended on Thursday, September 24, 2026 at 05:00 P.M. (IST). The facility for e-voting at AGM was also made available for those members who participated in the AGM and had not casted their vote(s) earlier by remote e-voting and the e-voting facility continued to be available for 15 minutes after conclusion of the meeting. The members were briefed about the procedure of e-voting at the AGM. Thereafter, Mr. Swapnil Jatinbhai Shah, Managing Director addressed the shareholders and requested Ms. Shilpa Sharma to take the proceeding further. The following resolutions as stated in the Notice of AGM were transacted at the meeting: Sr. No. Resolutions Type of Resolution 1. To receive, consider and adopt the Audited Standalone Ordinary Resolution and Consolidated Financial Statements of the Company for the (cid:976)inancial year ended March 31, 2026, together with the Reports of the Board of Directors and the Auditors thereon. 2. To appoint Mr. Sanjay Shaileshbhai Majmudar (DIN: Ordinary Resolution 00091305), who retires by rotation as a Director and being eligible, offers himself for re-appointment. 3. To appoint Mr. Arpit Deepakkumar Shah (DIN: Ordinary Resolution 07214641), who retires by rotation as a Director and being eligible, offers himself for re-appointment. 4. Appointment of Mr. Viranchi Arvindbhai Shah (DIN: Special Resolution 01598001) as a Non-Executive Independent Director of the Company for a Term of 5 (Five) Consecutive Years. 5. Approval of ‘Senores Pharmaceuticals Employee Stock Special Resolution Option Scheme 2026’. Senores Pharmaceuticals Limited 1101 to 1103, 11th Floor, South Tower, One42, Opp. Jayantilal Park, Ambali Bopal Road, Ahmedabad-380054, Gujarat, India P: +91 79 2999 9857 | E: info@senorespharma.com W: www.senorespharma.com | CIN No.: L24290GJ2017PLC100263 6. Approval of Grant of Employee Stock Options to the Special Resolution Employees of the Subsidiary Company(ies) of the Company under ‘Senores Pharmaceuticals Employee Stock Option Scheme 2026. The Company Secretary invited the members who had registered as speakers to raise their queries and offer their comments. Mr. Sanjay Shaileshbhai Majmudar, Chairman and Non-Executive, Non-Independent Director of the Company answered the queries raised by speaker shareholders in the meeting. Thereafter, the Chairman concluded the Meeting at 12:02 PM (IST) with v [Showing first 8,000 characters — download PDF for full document]